Literature DB >> 18552388

Decreased levels of the RNA splicing factor Prpf3 in mice and zebrafish do not cause photoreceptor degeneration.

John J Graziotto1, Chris F Inglehearn, Michael A Pack, Eric A Pierce.   

Abstract

PURPOSE: Pre-mRNA processing factor 3 (PRPF3) is a spliceosomal component essential for pre-mRNA processing. Mutations in PRPF3 have been implicated in retinitis pigmentosa (RP) 18 through an unknown mechanism. The authors created and characterized Prpf3 knockout mice and zebrafish to determine whether RP18 is a result of haploinsufficiency.
METHODS: Mice were produced from a Prpf3 gene trap cell line, and parameters of retinal function, structure, and RNA splicing were analyzed. The retinas of prpf3 insertional mutant zebrafish were also analyzed histologically.
RESULTS: Homozygous Prpf3 knockout mice do not survive to 14 days postfertilization (dpf), implying that this allele is required for early embryonic development. Homozygous Prpf3 knockout zebrafish die by 4dpf, well beyond the mid-blastula transition at which transcription activates. Zebrafish knockout embryos reveal abnormally high levels of cell death in the developing eye. Heterozygous Prpf3 knockout mice have less than the expected 50% reduction in Prpf3 at the mRNA and protein levels, implying compensatory expression from the wild-type allele. The heterozygous mice develop normally, with no changes in retinal function, no evidence for photoreceptor degeneration at up to 23 months of age, and no decrease in pre-mRNA splicing of transcripts mutated in other forms of RP in the retina. Similarly, heterozygous prpf3 knockout zebrafish develop normally and show no retinal degeneration up to 12 months of age.
CONCLUSIONS: These models suggest that RP18 is not a result of haploinsufficiency but instead arises from a toxic gain of function caused by missense mutations in PRPF3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18552388     DOI: 10.1167/iovs.07-1483

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Functional consequences of PRPF39 on distant genes and cisplatin sensitivity.

Authors:  Amy L Stark; Shannon M Delaney; Heather E Wheeler; Hae Kyung Im; M Eileen Dolan
Journal:  Hum Mol Genet       Date:  2012-07-05       Impact factor: 6.150

2.  Aberrant RNA splicing is the major pathogenic effect in a knock-in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation.

Authors:  Yan Li; Rachel Furhang; Amanda Ray; Todd Duncan; Joseph Soucy; Rashid Mahdi; Vijender Chaitankar; Linn Gieser; Eugenia Poliakov; Haohua Qian; Pinghu Liu; Lijin Dong; Igor B Rogozin; T Michael Redmond
Journal:  Hum Mutat       Date:  2019-01-25       Impact factor: 4.878

3.  Three gene-targeted mouse models of RNA splicing factor RP show late-onset RPE and retinal degeneration.

Authors:  John J Graziotto; Michael H Farkas; Kinga Bujakowska; Bertrand M Deramaudt; Qi Zhang; Emeline F Nandrot; Chris F Inglehearn; Shomi S Bhattacharya; Eric A Pierce
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

4.  Mutations in pre-mRNA processing factors 3, 8, and 31 cause dysfunction of the retinal pigment epithelium.

Authors:  Michael H Farkas; Deborah S Lew; Maria E Sousa; Kinga Bujakowska; Jonathan Chatagnon; Shomi S Bhattacharya; Eric A Pierce; Emeline F Nandrot
Journal:  Am J Pathol       Date:  2014-08-08       Impact factor: 4.307

5.  PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa.

Authors:  Goranka Tanackovic; Adriana Ransijn; Philippe Thibault; Sherif Abou Elela; Roscoe Klinck; Eliot L Berson; Benoit Chabot; Carlo Rivolta
Journal:  Hum Mol Genet       Date:  2011-03-05       Impact factor: 6.150

6.  RNA Splicing Factor Mutations That Cause Retinitis Pigmentosa Result in Circadian Dysregulation.

Authors:  Iryna Shakhmantsir; Scott J Dooley; Siddharth Kishore; Dechun Chen; Eric Pierce; Jean Bennett; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2019-11-15       Impact factor: 3.182

7.  Alternative splicing is frequent during early embryonic development in mouse.

Authors:  Timothée Revil; Daniel Gaffney; Christel Dias; Jacek Majewski; Loydie A Jerome-Majewska
Journal:  BMC Genomics       Date:  2010-06-23       Impact factor: 3.969

8.  Temporal and tissue specific regulation of RP-associated splicing factor genes PRPF3, PRPF31 and PRPC8--implications in the pathogenesis of RP.

Authors:  Huibi Cao; Jing Wu; Simon Lam; Rongqi Duan; Catherine Newnham; Robert S Molday; John J Graziotto; Eric A Pierce; Jim Hu
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

9.  An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth.

Authors:  Adam S Adler; Mark L McCleland; Sharon Yee; Murat Yaylaoglu; Sofia Hussain; Ely Cosino; Gabriel Quinones; Zora Modrusan; Somasekar Seshagiri; Eric Torres; Vivek S Chopra; Benjamin Haley; Zemin Zhang; Elizabeth M Blackwood; Mallika Singh; Melissa Junttila; Jean-Philippe Stephan; Jinfeng Liu; Gregoire Pau; Eric R Fearon; Zhaoshi Jiang; Ron Firestein
Journal:  Genes Dev       Date:  2014-05-01       Impact factor: 11.361

10.  Mutations in the Spliceosome Component CWC27 Cause Retinal Degeneration with or without Additional Developmental Anomalies.

Authors:  Mingchu Xu; Yajing Angela Xie; Hana Abouzeid; Christopher T Gordon; Alessia Fiorentino; Zixi Sun; Anna Lehman; Ihab S Osman; Rachayata Dharmat; Rosa Riveiro-Alvarez; Linda Bapst-Wicht; Darwin Babino; Gavin Arno; Virginia Busetto; Li Zhao; Hui Li; Miguel A Lopez-Martinez; Liliana F Azevedo; Laurence Hubert; Nikolas Pontikos; Aiden Eblimit; Isabel Lorda-Sanchez; Valeria Kheir; Vincent Plagnol; Myriam Oufadem; Zachry T Soens; Lizhu Yang; Christine Bole-Feysot; Rolph Pfundt; Nathalie Allaman-Pillet; Patrick Nitschké; Michael E Cheetham; Stanislas Lyonnet; Smriti A Agrawal; Huajin Li; Gaëtan Pinton; Michel Michaelides; Claude Besmond; Yumei Li; Zhisheng Yuan; Johannes von Lintig; Andrew R Webster; Hervé Le Hir; Peter Stoilov; Jeanne Amiel; Alison J Hardcastle; Carmen Ayuso; Ruifang Sui; Rui Chen; Rando Allikmets; Daniel F Schorderet
Journal:  Am J Hum Genet       Date:  2017-03-09       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.